An Evaluation of Systemic Vancomycin Dosing in Obese Patients
- PMID: 26716105
- PMCID: PMC4691676
- DOI: 10.1093/ofid/ofv176
An Evaluation of Systemic Vancomycin Dosing in Obese Patients
Abstract
We retrospectively identified 67 patients with severe or morbid obesity (body mass index ≥35 kg/m(2)) who had received intravenous vancomycin at our institution. We observed that an initial dose of 45 to 65 mg/kg vancomycin per day based upon ideal body weight rather than actual body weight was more predictive of initial trough concentrations between 15 and 20 mcg/mL.
Keywords: obese; pharmacokinetics; vancomycin.
Similar articles
-
Vancomycin Dosing Considerations in a Real-World Cohort of Obese and Extremely Obese Patients.Pharmacotherapy. 2015 Sep;35(9):869-75. doi: 10.1002/phar.1625. Epub 2015 Sep 6. Pharmacotherapy. 2015. PMID: 26343549
-
Evaluation of a New Vancomycin Dosing Protocol in Morbidly Obese Patients.Hosp Pharm. 2015 Oct;50(9):789-97. doi: 10.1310/hpj5009-789. Epub 2015 Oct 14. Hosp Pharm. 2015. PMID: 26912920 Free PMC article.
-
Achievement of Therapeutic Vancomycin Trough Serum Concentrations with Empiric Dosing in Neonatal Intensive Care Unit Patients.Pediatr Infect Dis J. 2015 Jul;34(7):742-7. doi: 10.1097/INF.0000000000000664. Pediatr Infect Dis J. 2015. PMID: 25629890
-
Pediatric Obesity: Pharmacokinetics and Implications for Drug Dosing.Clin Ther. 2015 Sep 1;37(9):1897-923. doi: 10.1016/j.clinthera.2015.05.495. Clin Ther. 2015. PMID: 26361823 Review.
-
Vancomycin Dosing in Obese Patients: Special Considerations and Novel Dosing Strategies.Ann Pharmacother. 2018 Jun;52(6):580-590. doi: 10.1177/1060028017750084. Epub 2017 Dec 21. Ann Pharmacother. 2018. PMID: 29262697 Review.
Cited by
-
Intravenous Vancomycin Dosing in the Elderly: A Focus on Clinical Issues and Practical Application.Drugs Aging. 2016 Dec;33(12):845-854. doi: 10.1007/s40266-016-0420-z. Drugs Aging. 2016. PMID: 27878526 Free PMC article. Review.
-
Evaluation of a vancomycin dosing nomogram in obese patients weighing at least 100 kilograms.Pharm Pract (Granada). 2018 Jul-Sep;16(3):1204. doi: 10.18549/PharmPract.2018.03.1204. Epub 2018 Aug 13. Pharm Pract (Granada). 2018. PMID: 30416622 Free PMC article.
-
Dose optimization of vancomycin in obese patients: A systematic review.Front Pharmacol. 2023 Mar 24;14:965284. doi: 10.3389/fphar.2023.965284. eCollection 2023. Front Pharmacol. 2023. PMID: 37033643 Free PMC article.
-
Population Pharmacokinetics and Dosing Simulation of Vancomycin Administered by Continuous Injection in Critically Ill Patient.Antibiotics (Basel). 2021 Oct 9;10(10):1228. doi: 10.3390/antibiotics10101228. Antibiotics (Basel). 2021. PMID: 34680809 Free PMC article.
-
Evaluation of Vancomycin Accumulation in Patients With Obesity.Open Forum Infect Dis. 2022 Sep 21;9(10):ofac491. doi: 10.1093/ofid/ofac491. eCollection 2022 Oct. Open Forum Infect Dis. 2022. PMID: 36267260 Free PMC article.
References
-
- Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of obesity in the United States, 2009–2010. NCHS Data Brief 2012; 1–8. - PubMed
-
- World Health Organization. Obesity and overweight. Fact sheet 311. Available at: http://www.who.int/mediacentre/factsheets/fs311/en/ Accessed 4 May 2015.
-
- Rybak M, Lomaestro B, Rotschafer JC et al. . Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm 2009; 66:82–98. - PubMed
-
- Adane ED, Herald M, Koura F. Pharmacokinetics of vancomycin in extremely obese patients with suspected or confirmed Staphylococcus aureus infections. Pharmacotherapy 2015; 35:127–39. - PubMed
-
- Bauer LA, Black DJ, Lill JS. Vancomycin dosing in morbidly obese patients. Eur J Clin Pharmacol 1998; 54:621–5. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources